SCHEMBL10035665

SCHEMBL10035665

CC(=O)c1cccc(C(=O)Nc2ccc(S(=O)(=O)O)cc2)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TIMP3 P35625 1/20 0.62
KMT2A Q03164 8/20 0.61
POLB P06746 1/20 0.61
HPGD P15428 1/20 0.57
SIRT2 Q8IXJ6 1/20 0.56
NPC1 O15118 3/20 0.56
KDM4E B2RXH2 1/20 0.56
LMNA P02545 1/20 0.56
MAPT P10636 1/20 0.56
MAPK1 P28482 1/20 0.56
MEN1 O00255 5/20 0.55
ALDH1A1 P00352 2/20 0.55
TSHR P16473 1/20 0.55
HTT P42858 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
MAOA P21397 1/20 0.54
MAOB P27338 1/20 0.54
TP53 P04637 1/20 0.54
PRMT1 Q99873 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13878433 0.87 KMT2A (0.76) KMT2APOLBHPGDNPC1MAPK1
SCHEMBL10035675 0.85 KMT2A (0.57) KMT2APOLBHPGDSIRT2NPC1
SCHEMBL13967735 0.85 KMT2A (0.63) KMT2APOLBHPGDSIRT2NPC1
SCHEMBL6245803 0.84 TIMP3 (0.84) TIMP3KMT2APOLBHPGDMEN1
SCHEMBL10797525 0.82 PTGS1 (0.62) TIMP3KMT2AKDM4EMEN1ALDH1A1
SCHEMBL15601840 0.82 TIMP3 (0.55) TIMP3KMT2AKDM4ELMNAMAPT
SCHEMBL14679075 0.81 PRMT1 (0.77) TIMP3KMT2APOLBHPGDNPC1
SCHEMBL13321807 0.79 KMT2A (0.56) KMT2APOLBHPGDSIRT2NPC1
SCHEMBL91946 0.79 MEN1 (0.55) TIMP3KMT2AHPGDNPC1LMNA
SCHEMBL11859460 0.79 CA1 (0.70) TIMP3KMT2APOLBHPGDNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8110329-B2 Charge controlling agent and toner CANON KABUSHIKI KAISHA (JP) 2012-02-07 US disclosed
US-8110329-B2 Charge controlling agent and toner CANON KABUSHIKI KAISHA (JP) 2012-02-07 US disclosed
US-20070111125-A1 CHARGE CONTROLLING AGENT AND TONER CANON KABUSHIKI KAISHA (JP) 2007-05-17 US disclosed
US-20070111125-A1 CHARGE CONTROLLING AGENT AND TONER CANON KABUSHIKI KAISHA (JP) 2007-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070111125-A1 CHARGE CONTROLLING AGENT AND TONER CA2, ACTR2, CA12 TIMP3 4432/4885KMT2A 218/4885POLB 2478/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.